Effects of antiretroviral drugs on carcinogenesis in human breast and cervical cells
No Thumbnail Available
Date
2015-04-20
Authors
Adefolaju, Gbenga Anthony
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Highly active antiretroviral therapy (HAART), a multidrug combination regimen,
commonly consisting of Nucleoside Reverse Transcriptase Inhibitors, non- Nucleoside
Reverse Transcriptase Inhibitors and Protease Inhibitors, has radically decreased mortality
and morbidity rates among people living with HIV/AIDS and is currently the treatment of
choice in South Africa and around the world. The emphasis of the original development of
the antiretroviral drugs was on clinical effectiveness (reducing mortality), before all other
considerations. Presently, emphasis has shifted from the initial short-term considerations to
the long-term undesirable or harmful effects induced by this treatment regimen. Studies on
the effects of HAART on the incidence and progression of HIV/AIDS associated cancers,
non-Hodgkin’s lymphoma, cervical cancer and Kaposi’s sarcoma have provided
contrasting data. While there has been a decrease in the incidence of Kaposi’s sarcoma,
HAART has reportedly not had a significant impact on the incidence of the other two
AIDS defining malignancies, while some evidence even suggests an increase in these
cancers. It has also been extensively reported that the widespread use of HAART has
increased the risk of non-AIDS defining malignancies, including breast cancer.
Whether individual antiretroviral compounds or their combinations are oncogenic is
therefore widely speculated. These speculations led to the investigation of the effects of
some of the antiretroviral drugs used in the South African treatment guidelines on the
expression of key apoptotic regulatory genes, BAX and BCL-2 in two human breast, MCF-
7 and MCF-10A and two human cervical cell lines, HCS-2 and NCE16IIA by Real Time
qPCR gene expression and immunofluorescence. This is because cancer is initiated when
there is an up-regulation of anti-apoptotic genes (e.g. BCL-2,) and down regulation of proapoptotic
genes (e.g. BAX).
Because the formation of new blood vessels from pre-existing vasculature (angiogenesis)
is required for cancer growth and development, this study also investigated the effects of
the antiretroviral drugs on the expression levels of key angiogenic regulatory genes;
hypothesising that the antiretroviral compounds might up-regulate pro-angiogenic
VEGF165a and/or down-regulate anti-angiogenic VEGF165b gene expression. This study also
evaluated the cytotoxicity of the antiretroviral drugs in normal and cancer cell lines of the
breast and cervix at clinically relevant concentrations of the drugs and at different time
points – 24, 48, 72 and 96 hours, employing the Neutral Red Toxicology/Viability Assay.
In addition, the potential anti-apoptotic effects of the protease inhibitors - LPV/r were
investigated by cell death detection ELISA and acridine orange staining.
This study shows that the antiretroviral drugs; tenofovir disoproxil fumarate, emtricitabine,
efavirenz, lopinavir, ritonavir and the two triple combinations (all at clinically relevant
concentrations which reflect their steady-state peak plasma concentrations in patients
receiving these drugs) demonstrated varying degrees of cytotoxicity in the normal breast
and cervical cells. The resulting DNA damage associated with cytotoxicity is strongly
implicated in the processes of tumor initiation. The results of the qPCR data demonstrated
differences in the response of the two tissue types used in this study, which, though is not
statistically significant, showed trends and often opposite trends between the breast and
cervical and between the normal and cancer cell lines. All the antiretroviral drugs and
combinations tested did not significantly alter BAX and BCL-2, VEGF165a and VEGF165b
gene expression in both cell lines. The protein localisation of BAX, BCL-2 and VEGF165b
were also not altered.
The protease inhibitors - LPV/r exhibited significant (p<0.05) inhibition of Camptothecin
induced apoptosis in the cervical cancer HCS-2 cell line but not in the normal immortalised
NCE16IIA or the two breast cell lines. This anti-apoptotic property of HIV protease
inhibitors, although shown here not to involve BAX or BCL-2 protein and RNA synthesis
might promote the development of cervical cancer.
Description
A thesis submitted to the School of Anatomical Sciences,
Faculty of Health Sciences, University of the Witwatersrand,
in fulfilment of the requirements for the degree of
Doctor of Philosophy
Johannesburg, 2014